You just read:

Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001

News provided by

Neuraltus Pharmaceuticals, Inc.

Jul 01, 2015, 08:30 ET